Oral versus Intravenous Antibiotics for Bone and Joint Infection

Ho Kwong Li, Ines Rombach, Rhea Zambellas, +56

New England Journal of Medicine

Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study

Nicola N. Lynskey, Elita Jauneikaite, Ho Kwong Li, +11

The Lancet Infectious Diseases

The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study

Jaime Lora-Tamayo, É. Senneville, Alba Ribera, +53

Clinical Infectious Diseases

Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes

Ana Vieira, Yu Wan, Yan Ryan, +26

Nature Communications

An Unsupported Preference for Intravenous Antibiotics

Ho Kwong Li, Ambrose Agweyu, Mike English, +1

PLoS Medicine

Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT

Matthew Scarborough, Ho Kwong Li, Ines Rombach, +37

Health Technology Assessment

Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial

Ho Kwong Li, Matthew Scarborough, Rhea Zambellas, +16

Trials

Emerging Invasive Group A <i>Streptococcus</i> M1 _UK Lineage Detected by Allele-Specific PCR, England, 20201

Xiangyun Zhi, Ho Kwong Li, Hanqi Li, +10

Emerging infectious diseases

Characterization of emergent toxigenic M1UK Streptococcus pyogenes and associated sublineages

Ho Kwong Li, Xiangyun Zhi, Ana Vieira, +11

Microbial Genomics

Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort study

Ho Kwong Li, Myrsini Kaforou, Jesús Rodríguez-Manzano, +21

The Lancet Microbe